KR20160125405A - 마이크로 니들·시트 - Google Patents
마이크로 니들·시트 Download PDFInfo
- Publication number
- KR20160125405A KR20160125405A KR1020167023955A KR20167023955A KR20160125405A KR 20160125405 A KR20160125405 A KR 20160125405A KR 1020167023955 A KR1020167023955 A KR 1020167023955A KR 20167023955 A KR20167023955 A KR 20167023955A KR 20160125405 A KR20160125405 A KR 20160125405A
- Authority
- KR
- South Korea
- Prior art keywords
- sheet
- micro needle
- skin
- micro
- needle
- Prior art date
Links
- 239000000463 material Substances 0.000 claims abstract description 39
- 239000004372 Polyvinyl alcohol Substances 0.000 claims abstract description 33
- 229920002451 polyvinyl alcohol Polymers 0.000 claims abstract description 33
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims abstract description 31
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims abstract description 26
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims abstract description 26
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims abstract description 26
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical group OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims abstract description 9
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 9
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims abstract description 9
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims abstract description 9
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 9
- 229920000578 graft copolymer Polymers 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims description 19
- 238000005452 bending Methods 0.000 claims description 7
- 210000003491 skin Anatomy 0.000 description 79
- 238000012360 testing method Methods 0.000 description 17
- 239000004480 active ingredient Substances 0.000 description 14
- 229940079593 drug Drugs 0.000 description 12
- 239000003814 drug Substances 0.000 description 12
- 206010015150 Erythema Diseases 0.000 description 9
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 9
- 231100000321 erythema Toxicity 0.000 description 9
- 206010030113 Oedema Diseases 0.000 description 8
- 239000002195 soluble material Substances 0.000 description 8
- 229960004393 lidocaine hydrochloride Drugs 0.000 description 7
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 7
- 239000000499 gel Substances 0.000 description 6
- 230000007794 irritation Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000001186 cumulative effect Effects 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- -1 polyethylene terephthalate Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920006254 polymer film Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 231100000245 skin permeability Toxicity 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000018040 scab formation Effects 0.000 description 1
- 230000036573 scar formation Effects 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0053—Methods for producing microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0061—Methods for using microneedles
Landscapes
- Health & Medical Sciences (AREA)
- Dermatology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
도 2 는 마이크로 니들·시트를 라이너에 고정시킨 상태를 나타내는 도면이다.
도 3 은 예시적인 어플리케이터의 사시도이다.
도 4 는 도 3 에 나타내는 어플리케이터의 사용 방법을 나타내는 도면이다.
도 5 는 마이크로 니들·시트의 적용을 모식적으로 나타내는 도면이다.
도 6 은 마이크로 니들·시트의 적용을 모식적으로 나타내는 도면이다.
도 7 은 마이크로 니들·시트의 적용을 모식적으로 나타내는 도면이다.
도 8 은 천자 (穿刺) 의 양태를 모식적으로 나타내는 도면이다.
도 9 는 실시예의 결과를 나타내는 표이다.
도 10 은 다른 실시예인 피부 투과 시험의 결과를 나타내는 그래프이다.
도 11 은 상기 피부 투과 시험의 결과를 나타내는 그래프이다.
피부 반응 평가 기준 (Draize) | |
홍반 및 가피 형성 | 평점 |
홍반 없음 | 0 |
매우 경도의 홍반 (간신히 식별할 수 있다) | 1 |
확실한 홍반 | 2 |
중간 정도 내지 고도 홍반 | 3 |
고도 홍반 (비트의 적색) 으로부터 약간의 가피 형성 (심부 손상) 까지 | 4 |
부종의 형성 | 평점 |
부종 없음 | 0 |
매우 경도의 부종 (간신히 식별할 수 있다) | 1 |
경도 부종 (확실한 팽융에 의한 명확한 가장자리를 식별할 수 있다) | 2 |
중간 정도 부종 (약 1 ㎜ 의 팽융) | 3 |
고도 부종 (약 1 ㎜ 의 팽융과 노출 범위를 초과한 퍼짐) | 4 |
11 : 주면,
12 : 마이크로 니들,
20 : 라이너,
30 : 어플리케이터,
31 : 본체,
32 : 제 1 관통공,
33 : 제 2 관통공,
34 : 점착제.
Claims (5)
- 시트의 주면을 대략 따라 그 시트에 형성된 복수의 마이크로 니들을 구비하고,
상기 마이크로 니들의 재료가, 하이드록시프로필메틸셀룰로오스, 하이드록시프로필셀룰로오스, 폴리비닐알코올, 및 폴리비닐알코올과 폴리에틸렌글리콜의 그래프트 코폴리머 중에서 선택되고,
상기 시트가 구부러짐으로써 상기 마이크로 니들이 상기 주면으로부터 세워지고, 세워진 그 마이크로 니들이 피부에 찔리는 마이크로 니들·시트. - 제 1 항에 있어서,
상기 시트의 두께가 10 ∼ 300 ㎛ 인 마이크로 니들·시트. - 제 1 항 또는 제 2 항에 있어서,
상기 세워진 마이크로 니들의 상기 피부에 대한 천자 각도가 34 도 이상 또한 180 도 미만인 마이크로 니들·시트. - 제 1 항 내지 제 3 항 중 어느 한 항에 있어서,
상기 주면으로부터 세워진 상기 마이크로 니들과, 상기 시트의 곡률 중심으로부터 그 마이크로 니들의 근원에 이르는 가상선이 이루는 최대 각도가 90 도보다 큰 마이크로 니들·시트. - 제 4 항에 있어서,
상기 최대 각도가 95 ∼ 130 도인 마이크로 니들·시트.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2014-037348 | 2014-02-27 | ||
JP2014037348 | 2014-02-27 | ||
PCT/JP2015/054641 WO2015129545A1 (ja) | 2014-02-27 | 2015-02-19 | マイクロニードル・シート |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20160125405A true KR20160125405A (ko) | 2016-10-31 |
KR102135495B1 KR102135495B1 (ko) | 2020-07-17 |
Family
ID=54008866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020167023955A KR102135495B1 (ko) | 2014-02-27 | 2015-02-19 | 마이크로 니들·시트 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20170049695A1 (ko) |
EP (1) | EP3111987B1 (ko) |
JP (1) | JP6325082B2 (ko) |
KR (1) | KR102135495B1 (ko) |
CN (1) | CN106061544B (ko) |
TW (1) | TWI630006B (ko) |
WO (1) | WO2015129545A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190082948A (ko) * | 2017-02-24 | 2019-07-10 | 히사미쓰 세이야꾸 가부시키가이샤 | 마이크로니들 디바이스 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10869998B2 (en) * | 2016-02-24 | 2020-12-22 | Hisamitsu Pharmaceutical Co., Inc. | Applicator |
CN109475728B (zh) * | 2016-09-01 | 2021-09-14 | 久光制药株式会社 | 微针片材 |
JP2020099513A (ja) * | 2018-12-21 | 2020-07-02 | ロレアル | マイクロニードルシートを使用するキット及び美容方法 |
US20240269446A1 (en) * | 2019-10-08 | 2024-08-15 | Hisamitsu Pharmaceutical Co., Inc. | Microneedle sheet and applicator |
JP7399295B2 (ja) * | 2020-04-06 | 2023-12-15 | イルロン カンパニー リミテッド | 化粧品吸収誘導用微細針が取り付けられた化粧品注入器及びその制作方法 |
CN116585606A (zh) * | 2023-06-15 | 2023-08-15 | 徕兄健康科技(威海)有限责任公司 | 一种可自调节的局部麻醉用微针贴片 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005503210A (ja) | 2001-09-14 | 2005-02-03 | ザ プロクター アンド ギャンブル カンパニー | 回転可能構造を用いて皮膚を介して組成物を皮膚に送達するための微細構造 |
US20050031676A1 (en) * | 2003-08-04 | 2005-02-10 | Wong Patrick S.L. | Method and device for enhancing transdermal agent flux |
KR20060029162A (ko) * | 2003-06-30 | 2006-04-04 | 알자 코포레이션 | 피부 피어싱 미세돌출부를 코팅하는 방법 |
US20080269685A1 (en) * | 2007-04-16 | 2008-10-30 | Parminder Singh | Solvent-cast microneedle arrays containing active |
WO2013187392A1 (ja) * | 2012-06-12 | 2013-12-19 | 久光製薬株式会社 | マイクロニードル・シート |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2195151T3 (es) * | 1996-06-18 | 2003-12-01 | Alza Corp | Dispositivo de mejora de aporte o de muestreo de agentes transdermicos. |
US6050988A (en) * | 1997-12-11 | 2000-04-18 | Alza Corporation | Device for enhancing transdermal agent flux |
US20030211619A1 (en) * | 2002-05-09 | 2003-11-13 | Lorin Olson | Continuous strip of fluid sampling and testing devices and methods of making, packaging and using the same |
JP2006345984A (ja) * | 2005-06-14 | 2006-12-28 | Nabtesco Corp | 機能付与用シート |
US20070185432A1 (en) * | 2005-09-19 | 2007-08-09 | Transport Pharmaceuticals, Inc. | Electrokinetic system and method for delivering methotrexate |
US7658728B2 (en) * | 2006-01-10 | 2010-02-09 | Yuzhakov Vadim V | Microneedle array, patch, and applicator for transdermal drug delivery |
US20070293816A1 (en) * | 2006-04-25 | 2007-12-20 | Alza Corporation | Microprojection Array Application with Grouped Microprojections for High Drug Loading |
US7785301B2 (en) * | 2006-11-28 | 2010-08-31 | Vadim V Yuzhakov | Tissue conforming microneedle array and patch for transdermal drug delivery or biological fluid collection |
JP5297595B2 (ja) * | 2007-03-20 | 2013-09-25 | 凸版印刷株式会社 | 針状体および針状体製造方法 |
US20100221314A1 (en) * | 2007-10-18 | 2010-09-02 | Hisamitsu Pharmaceutical Co., Inc. | Microneedle Device |
US8764712B2 (en) * | 2009-08-04 | 2014-07-01 | Cook Medical Technologies Llc | Micro-needle array and method of use thereof |
JP6327852B2 (ja) * | 2010-05-04 | 2018-05-23 | コリウム インターナショナル, インコーポレイテッド | 微小突起アレイを使用した副甲状腺ホルモンの経皮送達のための方法及びデバイス |
US20130331792A1 (en) * | 2011-01-18 | 2013-12-12 | The Brigham And Women's Hospital, Inc. | Device and uses thereof |
JP2013153866A (ja) * | 2012-01-27 | 2013-08-15 | Fujifilm Corp | 経皮吸収シート及び経皮吸収シートの製造方法 |
CN104321106B (zh) * | 2012-06-22 | 2017-05-24 | 凸版印刷株式会社 | 针状体及针状体制造方法 |
US20150057505A1 (en) * | 2013-08-22 | 2015-02-26 | Elwha Llc | Method for Administering a Medicament to a Fetus |
-
2015
- 2015-02-19 KR KR1020167023955A patent/KR102135495B1/ko active IP Right Grant
- 2015-02-19 US US15/119,983 patent/US20170049695A1/en not_active Abandoned
- 2015-02-19 WO PCT/JP2015/054641 patent/WO2015129545A1/ja active Application Filing
- 2015-02-19 CN CN201580010336.9A patent/CN106061544B/zh active Active
- 2015-02-19 EP EP15755798.4A patent/EP3111987B1/en active Active
- 2015-02-19 JP JP2016505166A patent/JP6325082B2/ja active Active
- 2015-02-26 TW TW104106313A patent/TWI630006B/zh active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005503210A (ja) | 2001-09-14 | 2005-02-03 | ザ プロクター アンド ギャンブル カンパニー | 回転可能構造を用いて皮膚を介して組成物を皮膚に送達するための微細構造 |
KR20060029162A (ko) * | 2003-06-30 | 2006-04-04 | 알자 코포레이션 | 피부 피어싱 미세돌출부를 코팅하는 방법 |
US20050031676A1 (en) * | 2003-08-04 | 2005-02-10 | Wong Patrick S.L. | Method and device for enhancing transdermal agent flux |
US20080269685A1 (en) * | 2007-04-16 | 2008-10-30 | Parminder Singh | Solvent-cast microneedle arrays containing active |
US9114238B2 (en) * | 2007-04-16 | 2015-08-25 | Corium International, Inc. | Solvent-cast microprotrusion arrays containing active ingredient |
WO2013187392A1 (ja) * | 2012-06-12 | 2013-12-19 | 久光製薬株式会社 | マイクロニードル・シート |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190082948A (ko) * | 2017-02-24 | 2019-07-10 | 히사미쓰 세이야꾸 가부시키가이샤 | 마이크로니들 디바이스 |
US11464956B2 (en) | 2017-02-24 | 2022-10-11 | Hisamitsu Pharmaceutical Co., Inc. | Microneedle device |
Also Published As
Publication number | Publication date |
---|---|
TWI630006B (zh) | 2018-07-21 |
JPWO2015129545A1 (ja) | 2017-03-30 |
CN106061544A (zh) | 2016-10-26 |
CN106061544B (zh) | 2019-11-26 |
EP3111987B1 (en) | 2022-04-20 |
KR102135495B1 (ko) | 2020-07-17 |
US20170049695A1 (en) | 2017-02-23 |
TW201545781A (zh) | 2015-12-16 |
JP6325082B2 (ja) | 2018-05-16 |
EP3111987A4 (en) | 2017-10-11 |
EP3111987A1 (en) | 2017-01-04 |
WO2015129545A1 (ja) | 2015-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102135495B1 (ko) | 마이크로 니들·시트 | |
TWI583412B (zh) | Micro Needle Cloth | |
JP5966156B2 (ja) | 剣山型マイクロニードルのアプリケータデバイス | |
US10201691B2 (en) | Article comprising a microneedle | |
US10099043B2 (en) | Hollow microneedle array article | |
CN106806354B (zh) | 一种聚丙烯酸酯柔曲性溶胀微针 | |
KR20230014702A (ko) | 고성능 마이크로니들 어레이 | |
EP3042690B1 (en) | Micro-needle sheet | |
EP3508247B1 (en) | Microneedle sheet | |
CN210494885U (zh) | 金属储药微针贴片 | |
TWI787652B (zh) | 微型針片材及施作器 | |
CN210494886U (zh) | 一种可溶性滚轮微针装置 | |
Bao et al. | A fabrication of whole-dissovable microneedles patch in larger area for transdermal drug delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0105 | International application |
Patent event date: 20160830 Patent event code: PA01051R01D Comment text: International Patent Application |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20170925 Comment text: Request for Examination of Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20190429 Patent event code: PE09021S01D |
|
E90F | Notification of reason for final refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Final Notice of Reason for Refusal Patent event date: 20191120 Patent event code: PE09021S02D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20200522 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20200713 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20200713 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20230619 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20240620 Start annual number: 5 End annual number: 5 |